REPORT TRACKS DRUGS OF CHOICE AMONG YOUTH

Cocaine Use Is Low, While Pervitin and Marijuana Are on Rise

On Nov. 14, police officers from the National Anti-Drug Squad (NPDC)
busted a four-member gang accused of producing and distributing
pervitin, a locally made methamphetamine. After what had been months
of investigation, police had tracked the criminal group to a Brno
apartment where three of the members were thought to be cooking up
pounds of pervitin in a rental flat.

"The suspects transported some of the drugs to Teplice, where they
exchanged it for heroin," says NPDC spokesman Bretislav Brejcha.

Although police are not yet certain exactly how much pervitin the
gang produced, the incident exemplifies a current trend on the local
illegal drug market: While other European countries register a
growing taste for cocaine, it's heroin and pervitin that remain the
hard drugs of choice for local drug users.

This is according to the European Monitoring Centre for Drugs and
Drug Addiction (EMCDDA), the European Union agency whose 2007 annual
report, released Nov. 22, maps new trends in substance abuse and
illegal drug trafficking throughout the EU. "With its stimulating
effects, cocaine is very similar to Czech pervitin," says Pavla
Chomynova, spokeswoman for the National Monitoring Center for Drugs
and Drug Abuse (NMCDDA), the EMCDDA's local branch.

"Pervitin is relatively easy to get. Its prices are substantially
lower than those of cocaine, so users seek it out more frequently," she says.

While more than 4.5 million Europeans reported using cocaine in the
past year, only one in 500 Czechs said they used the drug in 2006,
the report states.

"The percentages of cocaine use here are so marginal that our
institution had trouble incorporating them into some of the EU
statistics," says Viktor Mravcik, who directed the national research
contributing to the EU report.

While local cocaine use remains relatively low, pervitin production
and use are on the rise: In 2006, the NPDC registered 19,700 pervitin
users nationwide.

Due to its ubiquitous popularity and highly addictive character,
pervitin has not only made its way into small towns and dance
parties, but is also rising in use elsewhere in the region. The
report states, "Methamphetamines have become the No. 1 problem drugs
for individuals seeking treatment in Slovakia, and a high usage level
is now being recorded in certain subpopulations in Hungary."

Homegrown Addiction

Since the 1980s, pervitin production has consistently risen.

"Methamphetamine is basically a specifically Czech thing," Chomynova says.

While the origins of pervitin use can be traced as far back as World
War II, widespread use was first registered during the 1970s and
1980s. "That was when the drug made its debut in closed circles of
people who were able to cook the drug for their own use," Chomynova says.

At the time, pseudoephedrine, the drug's main component, was
relatively easy to get. Until its plant's closing in 2002, Roztoky u
Prahy, a town 6 kilometers (3.7 miles) north of Prague, had one of
the largest pseudoephedrine producing factories in the world, Chomynova says.

Even now, five years after the plant's shutdown, "the individuals who
cook and use pervitin are still frequently able to get the
pseudoephedrine from freely available medicines," she adds.

While the initial effects of pervitin are similar to those of
cocaine, the long-term consequences differ. "Unlike cocaine use,
pervitin use can cause long-term psychological damage, leading to
certain types of psychosis," Chomynova says.

Aside from the spreading popularity of pervitin and a stabilized but
still high number of heroin users, the Czech Republic also tops EU
charts for marijuana use among young people. On average, 13 percent
of young Europeans have used marijuana in the past year. With a
national average of 19.3 percent, the Czech Republic trails Spain
with the EU's second-highest rate of marijuana use among young people.

However, effective prevention has brought this trend to a decline,
down 2 percent to 4 percent since 2002, Mravcik says.

Despite these trends, the overall situation in Europe may be
improving. "After over a decade of rising drug use, Europe may now be
entering a more stable phase," the report states. Heroin use and drug
injecting have become generally less common, and, following a
sustained period of growth since 1990s, "new data suggest that levels
of cannabis use may now be stabilizing."

Still, these positive developments are tarnished by a sobering bottom
line. "Europe risks failing to meet its targets to reduce
drug-related deaths," the report states. There are "between 7,000 and
8,000 overdose deaths per year, with no downward trend detectable in
the most recent data."